IE
OACCU

Israel Englander’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

Israel Englander’s Portfolio OACCU Stock Details OACCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-529,858
Closed -$5.53M – 6449
2025
Q1 		$5.53M Sell
529,858
-422,564
-44% -$4.31M ﹤0.01% 2753
2024
Q4 		$9.65M Buy
+952,422
New +$9.6M ﹤0.01% 2214

Other funds holding OACCU

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's OACCU Position: Q2 2025 in Review

Israel Englander sold out of Oaktree Acquisition Corp III Life Sciences Unit (OACCU) in Q2 2025, closing a stake of 529,858 shares — an estimated $5.53M sold.

Israel Englander first reported a position in OACCU in Q4 2024 and held it in 2 quarters. The position peaked at $9.65M in Q4 2024. 6 funds tracked by Wall St. Rank hold OACCU as of Q2 2025.

  • Israel Englander reported no remaining Oaktree Acquisition Corp III Life Sciences Unit position as of Q2 2025 after selling out during the quarter.
  • Israel Englander sold 529,858 Oaktree Acquisition Corp III Life Sciences Unit shares in Q2 2025, an estimated $5.53M.
  • Israel Englander first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q4 2024 and held it in 2 quarters.
  • Israel Englander's Oaktree Acquisition Corp III Life Sciences Unit position peaked at $9.65M in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.